Cargando…

Experiences of healthcare personnel on the efficacy of artemisinin-based combination therapy and malaria diagnosis in hospitals in Uganda

BACKGROUND: The risk of widespread resistance to artemisinin-based combination therapy (ACT) remains high in Uganda following detection of Plasmodium falciparum parasites with delayed artemisinin clearance genotype and phenotype. Establishment of context specific interventions to mitigate emergence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ocan, Moses, Bakubi, Racheal, Tayebwa, Mordecai, Basemera, Joan, Nsobya, Sam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683277/ https://www.ncbi.nlm.nih.gov/pubmed/38012717 http://dx.doi.org/10.1186/s12936-023-04800-2

Ejemplares similares

Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
por: Ocan, Moses, et al.
Publicado: (2023)

Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria in Uganda
por: Bukirwa, Hasifa, et al.
Publicado: (2006)

Artemisinin versus Nonartemisinin Combination Therapy for Uncomplicated Malaria: Randomized Clinical Trials from Four Sites in Uganda
por: Yeka, Adoke, et al.
Publicado: (2005)

Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda
por: Ocan, Moses, et al.
Publicado: (2022)

Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors
por: Ocan, Moses, et al.
Publicado: (2019)

K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors
por: Ocan, Moses, et al.
Publicado: (2019)

Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
por: Ebong, Chris, et al.
Publicado: (2021)

Prevalence of chloroquine resistance alleles among Plasmodium falciparum parasites in countries affected by malaria disease since change of treatment policy: a systematic review protocol
por: Ocan, Moses, et al.
Publicado: (2018)

Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
por: Ebong, Chris, et al.
Publicado: (2022)

Antimicrobial stewardship: Attitudes and practices of healthcare providers in selected health facilities in Uganda
por: Kimbowa, Isaac Magulu, et al.
Publicado: (2022)

Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
por: Whegang, Solange Youdom, et al.
Publicado: (2010)

K13-propeller gene polymorphisms in Plasmodium falciparum parasite population: a systematic review protocol of burden and associated factors
por: Ocan, Moses, et al.
Publicado: (2018)

Antibody levels and protection after Hepatitis B vaccine in adult vaccinated healthcare workers in northern Uganda
por: Ocan, Moses, et al.
Publicado: (2022)

Healthcare Professional Preferences for Prescribing Artemisinins and Quinine for Malaria in Burundi
por: Niyonkuru, Aîné-Ernest, et al.
Publicado: (2021)

Characteristics of antimicrobial stewardship programmes in hospitals of Uganda
por: Kimbowa, Isaac Magulu, et al.
Publicado: (2022)

Epidemiological Dynamics of Extended-Spectrum β-Lactamase- or AmpC β-Lactamase-Producing Escherichia coli Screened in Apparently Healthy Chickens in Uganda
por: Kakooza, Steven, et al.
Publicado: (2021)

Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018
por: Lyus, Rosanna, et al.
Publicado: (2020)

Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda
por: Ndagije, Helen Byomire, et al.
Publicado: (2020)

Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda
por: Cohen, Jessica L, et al.
Publicado: (2012)

Household perceptions and subjective valuations of indoor residual spraying programmes to control malaria in northern Uganda
por: Brown, Zachary S., et al.
Publicado: (2016)

Factors predicting home storage of medicines in Northern Uganda
por: Ocan, Moses, et al.
Publicado: (2014)

Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance
por: Jones, Sam, et al.
Publicado: (2019)

Patterns and Predictors of Self-Medication in Northern Uganda
por: Ocan, Moses, et al.
Publicado: (2014)

Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar
por: Ménard, Didier, et al.
Publicado: (2007)

Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated Plasmodium falciparum malaria in the Republic of Congo
por: van den Broek, Ingrid, et al.
Publicado: (2006)

Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review
por: Visser, Benjamin J, et al.
Publicado: (2014)

Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria
por: Nambozi, Michael, et al.
Publicado: (2017)

The consequences of artemisinin resistance in falciparum malaria
por: White, Nicholas J
Publicado: (2012)

Perspective: Artemisinin-Resistant Malaria and the Wolf
por: Meshnick, Steve
Publicado: (2012)

Genomic epidemiology of artemisinin resistant malaria
Publicado: (2016)

Genetic diversity and genetic relatedness in Plasmodium falciparum parasite population in individuals with uncomplicated malaria based on microsatellite typing in Eastern and Western regions of Uganda, 2019–2020
por: Bosco, Agaba B., et al.
Publicado: (2021)

No Evidence of Decreased Artemisinin Efficacy in a High-Transmission Malaria Setting in Mali
por: Ng, Caroline L., et al.
Publicado: (2012)

Efficacy and Safety of Artemisinin-Piperaquine for the Treatment of Uncomplicated Malaria: A Systematic Review
por: Wang, Qi, et al.
Publicado: (2020)

Access to artemisinin combination therapy for malaria in remote areas of Cambodia
por: Yeung, Shunmay, et al.
Publicado: (2008)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022)

Are Artemisinin-Based Combination Therapies For Malaria Beginning To Fail in Africa?
por: Rosenthal, Philip J.
Publicado: (2021)

Performance of Kalon herpes simplex virus 2 assay using dried blood spots among young women in Uganda
por: Nsobya, Sam L., et al.
Publicado: (2016)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
por: Mayxay, Mayfong, et al.
Publicado: (2012)

Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial
por: Anvikar, Anupkumar R., et al.
Publicado: (2018)

Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono district, Uganda
por: Hansen, Kristian Schultz, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qk2681k8f3br93p6rci6vjqkmc